NuVasive (NUVA) Reports In-Line Q2 EPS, Revenues Beat; Offers FY18 EPS Outlook Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
NuVasive Announces Second Quarter 2018 Financial Results
July 31, 2018 4:05 PM EDTSAN DIEGO, July 31, 2018 /PRNewswire/ --Â NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced financial results for the quarter ended June 30, 2018.Â
Second Quarter 2018 Highlights
Revenue increased 8.5% to $281.6 million, or 7.7% on a constant currency basis; GAAP operating profit margin of 10.1%; Non-GAAP... More